Notice of Closed Meeting, 64898 [2019-25454]
Download as PDF
64898
Federal Register / Vol. 84, No. 227 / Monday, November 25, 2019 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
PAR 18–812, NIOSH Member Conflict.
Date: February 11, 2020.
Time: 1:00 p.m.–4:00 p.m., EST.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For further information contact: Nina
Turner, Ph.D., Scientific Review Officer,
Office of Extramural Programs, CDC,
1095 Willowdale Road, Morgantown,
West Virginia 26506; telephone: (304)
285–5976; email: nxt2@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–25454 Filed 11–22–19; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
17:31 Nov 22, 2019
Jkt 250001
1. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Centers for Medicare & Medicaid
Paperwork@cms.hhs.gov.
Services
2. Call the Reports Clearance Office at
(410)
786–1326.
[Document Identifier CMS–10224]
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
Agency Information Collection
Activities: Submission for OMB
SUPPLEMENTARY INFORMATION: Under the
Review; Comment Request
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
AGENCY: Centers for Medicare &
must obtain approval from the Office of
Medicaid Services, HHS.
Management and Budget (OMB) for each
ACTION: Notice.
collection of information they conduct
or sponsor. The term ‘‘collection of
SUMMARY: The Centers for Medicare &
Medicaid Services (CMS) is announcing information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
an opportunity for the public to
includes agency requests or
comment on CMS’ intention to collect
requirements that members of the public
information from the public. Under the
submit reports, keep records, or provide
Paperwork Reduction Act of 1995
information to a third party. Section
(PRA), federal agencies are required to
3506(c)(2)(A) of the PRA (44 U.S.C.
publish notice in the Federal Register
3506(c)(2)(A)) requires federal agencies
concerning each proposed collection of
to publish a 30-day notice in the
information, including each proposed
extension or reinstatement of an existing Federal Register concerning each
proposed collection of information,
collection of information, and to allow
including each proposed extension or
a second opportunity for public
reinstatement of an existing collection
comment on the notice. Interested
of information, before submitting the
persons are invited to send comments
collection to OMB for approval. To
regarding the burden estimate or any
comply with this requirement, CMS is
other aspect of this collection of
information, including the necessity and publishing this notice that summarizes
the following proposed collection(s) of
utility of the proposed information
collection for the proper performance of information for public comment:
1. Type of Information Collection
the agency’s functions, the accuracy of
Request: Revision of a currently
the estimated burden, ways to enhance
approved collection; Title of
the quality, utility, and clarity of the
information to be collected, and the use Information Collection: Healthcare
Common Procedure Coding System
of automated collection techniques or
other forms of information technology to (HCPCS)—Level II Code Modification
Request Process; Use: In October 2003,
minimize the information collection
the Secretary of Health and Human
burden.
Services (HHS) delegated authority
DATES: Comments on the collection(s) of under the Health Insurance Portability
information must be received by the
and Accountability Act (HIPAA)
OMB desk officer by December 26, 2019. legislation to Centers for Medicare and
Medicaid Services (CMS) to maintain
ADDRESSES: When commenting on the
and distribute HCPCS Level II Codes. As
proposed information collections,
please reference the document identifier stated in 42 CFR Sec. 414.40 (a) CMS
establishes uniform national definitions
or OMB control number. To be assured
of services, codes to represent services,
consideration, comments and
and payment modifiers to the codes.
recommendations must be received by
The HCPCS code set has been
the OMB desk officer via one of the
following transmissions: OMB, Office of maintained and distributed via
modifications of codes, modifiers and
Information and Regulatory Affairs,
descriptions, as a direct result of data
Attention: CMS Desk Officer, Fax
received from applicants. Thus,
Number: (202) 395–5806 OR, Email:
information collected in the application
OIRA_submission@omb.eop.gov.
is significant to codeset maintenance.
To obtain copies of a supporting
The HCPCS code set maintenance is an
statement and any related forms for the
ongoing process, as changes are
proposed collection(s) summarized in
implemented and updated annually;
this notice, you may make your request
therefore, the process requires continual
using one of following:
collection of information from
1. Access CMS’ website address at
website address at https://www.cms.gov/ applicants on an annual basis. As new
technology evolves and new devices,
Regulations-and-Guidance/Legislation/
drugs and supplies are introduced to the
PaperworkReductionActof1995/PRAmarket, applicants submit applications
Listing.html.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
E:\FR\FM\25NON1.SGM
25NON1
Agencies
[Federal Register Volume 84, Number 227 (Monday, November 25, 2019)]
[Notices]
[Page 64898]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25454]
[[Page 64898]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--PAR 18-812, NIOSH Member
Conflict.
Date: February 11, 2020.
Time: 1:00 p.m.-4:00 p.m., EST.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For further information contact: Nina Turner, Ph.D., Scientific
Review Officer, Office of Extramural Programs, CDC, 1095 Willowdale
Road, Morgantown, West Virginia 26506; telephone: (304) 285-5976;
email: [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-25454 Filed 11-22-19; 8:45 am]
BILLING CODE 4163-18-P